CABINET - trial - Cabozantinib for NET
Thu Feb 20 2025
Back to basics as I break down a trial
| Publishes | Daily or near-daily | Episodes | 397 | Founded | N/A |
|---|---|---|---|---|---|
| Number of Listeners | Category | Science | |||
CABINET - trial - Cabozantinib for NET
Thu Feb 20 2025
Back to basics as I break down a trial
Public ranges are rounded for privacy. Unlock the full report for exact values.
Social links
No public profiles listed.
We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.
Want to get booked on podcasts like this?
PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.
This show is Rank #39311 by pitch volume, with 7 pitches sent by PodPitch users.
We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.
Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service. A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
Daily or near-daily
PodPitch shows a public audience band (like "20K–40K / month"). Book a demo to unlock exact audience estimates and how we calculate them.
Use PodPitch to access verified outreach details and pitch recommendations for Plenary Session. Start at https://podpitch.com/try/1.
This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.
Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.